StockData
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (INM) stock

INMNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as MTRI
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$1.37+0.05 (+3.44%)

Close on Oct 19, 2026Market cap $102.18MP/E –Yield –

InMed Pharmaceuticals statistics

46 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$102.18M
$272.32M
Enterprise Value
$101.08M
$146.23M

Share statisticsIndustry

Shares Change (YoY)
150.7%
10.8%
Shares Change (QoQ)
2.89%
0.50%
Shares Held by Institutions
49.1%
56.4%

Stock price statisticsIndustry

52-Week High
$23.30
–
52-Week Low
$5.70
–
20-Day Moving Average
$15.42
–
50-Day Moving Average
$14.22
–
200-Day Moving Average
$12.28
–
Average True Range (14)
$2.16
–
Price Change (1 Week)
19.5%
-1.15%
Price Change (1 Month)
39.8%
-4.87%
Price Change (3 Months)
27.4%
-21.0%
Price Change (6 Months)
190.6%
-20.6%
Price Change (YTD)
75.5%
-23.6%
Price Change (1 Year)
7.51%
-22.4%
Price Change (3 Years)
-75.9%
-29.5%
Price Change (5 Years)
-99.7%
-77.9%
Average Volume (10 Days)
43,308
–
Average Volume (20 Days)
25,477
–
Average Volume (90 Days)
70,900
–
Relative Volume
0.17
0.70
Relative Strength Index (14)
61.0
43.4
Volatility (1 Year)
161.3%
80.1%
Beta (5 Years)
2.21
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-253.4%
-49.9%
Return on Assets (ROA)
-179.5%
-40.6%

EfficiencyIndustry

Profits Per Employee
-$2.19M
-$689.41K
Employee Count
6
74
WACC
16.2%
10.2%

Income statement (TTM)Industry

Pretax Income
-$11.66M
-$12.95M
Net Income
-$13.16M
-$22.35M
EBITDA
-$11.50M
-$17.21M
EPS (Diluted)
-$2.90
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$1.10M
$17.76M
Net Cash Per Share
$0.20
$0.80
Equity (Book Value)
-$1.20M
$53.89M
Book Value Per Share
-$0.22
$1.50
Tangible Book Value
-$1.20M
$27.13M

Cash flow (TTM)Industry

Operating Cash Flow
-$7.86M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-12.9%
-21.8%

Scores and fair valueIndustry

Altman Z-Score
-117.64
0.23
Piotroski F-Score
1
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodINMS&P 500DifferenceINM per yearS&P 500 per year
1 month+0.4%+0.6%−0.2 pts
3 months-10.2%+3.4%−13.5 pts
Year to date+28.8%+13.3%+15.5 pts
1 year-35.0%+16.6%−51.6 pts
3 years-88.6%+86.4%−175.0 pts-51.5%+23.1%
5 years-99.8%+81.9%−181.7 pts-72.3%+12.7%
10 years-99.9%+318.9%−418.8 pts-52.5%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M INM shares were sold short on Oct 30, 2026, up 855.8% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 47.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202663,409+855.8%69,6341.0
Oct 15, 20266,634-80.5%34,1061.0
Sep 30, 202634,080+114.7%78,9011.0
Sep 15, 202615,876-48.4%44,8501.0
Aug 31, 202630,769-57.5%102,1031.0
Aug 14, 202672,430-12.8%63,4251.1
Jul 31, 202683,065-30.3%4,363,9771.0
Jul 15, 2026119,223-15.9%45,3942.6
Jun 30, 2026141,779-0.9%33,0284.3
Jun 15, 2026143,091+6.7%97,7171.5
May 29, 2026134,109+404.2%10,761,1011.0
May 15, 202626,599-25.0%18,3731.4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?